Spese di spedizione:
EUR 72,50
Da: Belgio a: U.S.A.
Spese di spedizione:
EUR 2,38
In U.S.A.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New. Codice articolo 45377076-n
Quantità: 5 disponibili
Da: Grand Eagle Retail, Wilmington, DE, U.S.A.
Hardcover. Condizione: new. Hardcover. Volume 24, entitled Targeted Metallo-Drugs: Design, Development, and Modes of Action, of the series Metal Ions in Life Sciences (MILS), fosters inter-disciplinary research in the vibrant field of Biological Inorganic Chemistry. Inspired by the clinical success of cisplatin as a leading anticancer drug but mindful of the shortcomings associated with its use including dose-limiting toxic side effects and acquired or intrinsic drug resistance, scientists across the globe have been endeavoring to identify new metallo-drugs for therapeutic exploitation. This has led to innovative metallo-drug candidates that (i) enhance cancer cell selectivity, thus reducing toxic side effects, and/or (ii) possess new modes of action to improve efficacy and also target resistance pathways. This and more are captured in MILS- 24 which consists of 12 comprehensive, well-illustrated, and up to date chapters with over 1600 citations, 100 figures, and 10 tables with key contributions from 32 international experts from Europe, Asia, and North and South America. MILS- 24 not only keeps the scientific community abreast of latest developments, it also serves as an invaluable resource to stimulate further research on targeted metallo-drug design and development.It covers anticancer, antimicrobial, antiviral, and other agents, such as those targeting tropical diseases and cyanide poisoning and radiometals in molecular imaging and therapyIt highlights recent metallo-drug developments targeting COVID-19It features advanced spectroscopic methods and metallomics as important tools to elucidate the modes of actions of metallo-drugs This MILS-24 volume provides a comprehensive overview of recent advances in the development of new metal-based drugs as anti-cancer, anti-microbial and anti-viral agents which have been designed specifically to overcome toxic side effects and/or resistance issues associated with current drug treatments. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Codice articolo 9781032223308
Quantità: 1 disponibili
Da: Ria Christie Collections, Uxbridge, Regno Unito
Condizione: New. In. Codice articolo ria9781032223308_new
Quantità: 1 disponibili
Da: GreatBookPricesUK, Castle Donington, DERBY, Regno Unito
Condizione: New. Codice articolo 45377076-n
Quantità: 2 disponibili
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
Hardback. Condizione: New. New copy - Usually dispatched within 4 working days. Codice articolo B9781032223308
Quantità: 1 disponibili
Da: Speedyhen, London, Regno Unito
Condizione: NEW. Codice articolo NW9781032223308
Quantità: 1 disponibili
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Condizione: New. 2023. 1st Edition. Hardcover. . . . . . Codice articolo V9781032223308
Quantità: 1 disponibili
Da: Revaluation Books, Exeter, Regno Unito
Hardcover. Condizione: Brand New. 1st edition. 369 pages. 9.50x6.50x0.75 inches. In Stock. Codice articolo __1032223308
Quantità: 1 disponibili
Da: AHA-BUCH GmbH, Einbeck, Germania
Buch. Condizione: Neu. Neuware - This MILS-24 volume provides a comprehensive overview of recent advances in the development of new metal-based drugs as anti-cancer, anti-microbial and anti-viral agents which have been designed specifically to overcome toxic side effects and/or resistance issues associated with current drug treatments. Codice articolo 9781032223308
Quantità: 2 disponibili
Da: moluna, Greven, Germania
Gebunden. Condizione: New. Etelka Farkas is Emeritus Professor (2016) at the Faculty of Science and Technology, Department of Inorganic and Analytical Chemistry at the University of Debrecen, Hungary. After receiving her scientific degree (D.Sc.) from the Hungaria. Codice articolo 780207450
Quantità: 1 disponibili